Journal article · 2019 · Open access

Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre

Kristina Star, Lovisa Sandberg, Tomas Bergvall, Imti Choonara, Pia Caduff‐Janosa, Ivor Ralph Edwards

Pharmacoepidemiology and Drug Safety, 28(5), 680–689 · Published 15 February 2019 · DOI 10.1002/pds.4734

Open PDFView at the publisherCite this paper

In brief

“Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre” is a 2019 journal article by Kristina Star and 5 co-authors, published in Pharmacoepidemiology and Drug Safety. OpenAlex counts 31 citations as of 19 November 2026, which puts it in the top 5% of works published in 2019 by citations. It is open access under a CC BY licence: the full text is free to read at Pharmacoepidemiology and Drug Safety.

Citations
31
Most cited in
2020 (9)
Field-weighted impact
3.42
References
23
Authors
6

Abstract

PURPOSE: The purpose of this study is to uncover previously unrecognised risks of medicines in paediatric pharmacovigilance reports and thereby advance a safer use of medicines in paediatrics. METHODS: Individual case safety reports (ICSRs) with ages less than 18 years were retrieved from VigiBase, the World Health Organization (WHO) global database of ICSRs, in September 2014. The reports were grouped according to the following age spans: 0 to 27 days; 28 days to 23 months; 2 to 11 years; and 12 to 17 years. vigiRank, a data-driven predictive model for emerging safety signals, was used to prioritise the list of drug events by age groups. The list was manually assessed, and potential signals were identified to undergo in-depth assessment to determine whether a signal should be communicated. RESULTS: A total of 472 drug-event pairs by paediatric age groups were the subject of an initial manual assessment. Twenty-seven drug events from the two older age groups were classified as potential signals. An in-depth assessment resulted in eight signals, of which one concerned harm in connection with off-label use of dextromethorphan and another with accidental overdose of olanzapine by young children, and the remaining signals referred to potentially new causal associations for atomoxetine (two signals), temozolamide, deferasirox, levetiracetam, and desloratadine that could be relevant also for adults. CONCLUSIONS: Clinically relevant signals were uncovered in VigiBase by using vigiRank applied to paediatric age groups. Further refinement of the methodology is needed to identify signals in reports with ages under 2 years and to capture signals specific to the paediatric population as a risk group.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Star, K., Sandberg, L., Bergvall, T., Choonara, I., Caduff‐Janosa, P., & Edwards, I. R. (2019). Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre. Pharmacoepidemiology and Drug Safety, 28(5), 680–689. https://doi.org/10.1002/pds.4734

MLA 9

Star, Kristina, et al. “Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre.” Pharmacoepidemiology and Drug Safety, vol. 28, no. 5, 2019, pp. 680–689. https://doi.org/10.1002/pds.4734.

Chicago

Star, Kristina, Lovisa Sandberg, Tomas Bergvall, Imti Choonara, Pia Caduff‐Janosa, and Ivor Ralph Edwards. 2019. “Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre.” Pharmacoepidemiology and Drug Safety 28 (5): 680–689. https://doi.org/10.1002/pds.4734.

Harvard

Star, K. et al. (2019) ‘Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre’, Pharmacoepidemiology and Drug Safety, 28(5), pp. 680–689. doi:10.1002/pds.4734.

IEEE

K. Star, L. Sandberg, T. Bergvall, I. Choonara, P. Caduff‐Janosa, and I. R. Edwards, “Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre,” Pharmacoepidemiology and Drug Safety, vol. 28, no. 5, pp. 680–689, 2019, doi: 10.1002/pds.4734.

BibTeX

@article{star2019paediatric,
  title     = {{Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre}},
  author    = {Star, Kristina and Sandberg, Lovisa and Bergvall, Tomas and Choonara, Imti and Caduff‐Janosa, Pia and Edwards, Ivor Ralph},
  journal   = {Pharmacoepidemiology and Drug Safety},
  year      = {2019},
  volume    = {28},
  number    = {5},
  pages     = {680--689},
  doi       = {10.1002/pds.4734},
  url       = {https://doi.org/10.1002/pds.4734}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201955
202099
202166
202333
202455
202633

Its field-weighted citation impact is 3.42: it has been cited 3.42 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions

  • safety signals
  • individual case safety reports
  • VigiBase
  • atomoxetine
  • temozolomide
  • deferasirox
  • levetiracetam
  • desloratadine

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Star, K., Sandberg, L., Bergvall, T., Choonara, I., Caduff‐Janosa, P., & Edwards, I. R. (2019). Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre. Pharmacoepidemiology and Drug Safety, 28(5), 680–689. https://doi.org/10.1002/pds.4734

How many times has this paper been cited?

31 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Pharmacoepidemiology and Drug Safety: sign in and open the PDF from this page.

Who wrote this paper?

Kristina Star, Lovisa Sandberg, Tomas Bergvall, Imti Choonara, Pia Caduff‐Janosa, Ivor Ralph Edwards.

What is the DOI of this paper?

10.1002/pds.4734, permanently at https://doi.org/10.1002/pds.4734. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.